Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Sales, net	$ 22,739	$ 20,323	$ 44,892	$ 42,879
Cost of sales	9,046	7,967	17,743	17,005
Gross profit	13,693	12,356	27,149	25,874
Operating expenses:
Sales and marketing	6,969	6,009	13,709	13,883
Research and development	1,316	1,365	3,411	2,558
General and administrative	5,664	7,298	11,016	13,717
Total operating expenses	13,949	14,672	28,136	30,158
Operating loss	(256)	(2,316)	(987)	(4,284)
Nonoperating income:
Interest income, net	241	125	480	191
Net loss	$ (15)	$ (2,191)	$ (507)	$ (4,093)
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ 0.00	$ (0.03)	$ (0.01)	$ (0.05)
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ 0.00	$ (0.03)	$ (0.01)	$ (0.05)
Basic weighted average common shares outstanding (in shares)	75,559	74,967	75,394	74,882
Diluted weighted average common shares outstanding (in shares)	75,559	74,967	75,394	74,882